Hubei Biocause Pharmaceutical (000627) — Cash Flow Reinvestment Rate
Hubei Biocause Pharmaceutical (000627) has a Cash Flow Reinvestment Rate of 35.61x as of September 2023, reinvesting CN¥9.83 Billion (capex CN¥10.51 Million plus investments CN¥-9.82 Billion) from operating cash flow of CN¥276.06 Million. See Hubei Biocause Pharmaceutical free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hubei Biocause Pharmaceutical Cash Flow Reinvestment Rate (2001–2023)
Historical reinvestment intensity for Hubei Biocause Pharmaceutical across 16 annual periods. For the full cash flow conversion analysis, see 000627 cash flow metrics.
Annual Cash Flow Reinvestment Rate for Hubei Biocause Pharmaceutical (2001–2023)
Year-by-year capital reinvestment analysis for Hubei Biocause Pharmaceutical. See Hubei Biocause Pharmaceutical leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 0.39x | CN¥3.71 Billion | CN¥9.53 Billion | CN¥67.53 Million | ▼ -81.4% |
| 2022 | 2.09x | CN¥15.75 Billion | CN¥7.52 Billion | CN¥135.06 Million | ▼ -64.4% |
| 2021 | 5.88x | CN¥24.52 Billion | CN¥4.17 Billion | CN¥287.13 Million | ▲ +854.9% |
| 2020 | 0.62x | CN¥13.18 Billion | CN¥21.42 Billion | CN¥319.51 Million | ▼ -60.7% |
| 2019 | 1.57x | CN¥44.77 Billion | CN¥28.60 Billion | CN¥717.10 Million | ▲ +38.1% |
| 2018 | 1.13x | CN¥16.99 Billion | CN¥14.98 Billion | CN¥274.67 Million | ▼ -97.2% |
| 2017 | 40.64x | CN¥17.54 Billion | CN¥431.58 Million | CN¥778.95 Million | ▲ +3589.5% |
| 2013 | 1.10x | CN¥143.80 Million | CN¥130.53 Million | CN¥143.80 Million | ▼ -19.6% |
| 2012 | 1.37x | CN¥128.50 Million | CN¥93.79 Million | CN¥128.50 Million | ▼ -38.6% |
| 2011 | 2.23x | CN¥149.37 Million | CN¥66.95 Million | CN¥149.37 Million | ▲ +438.3% |
| 2010 | 0.41x | CN¥93.09 Million | CN¥224.58 Million | CN¥93.09 Million | ▼ -24.1% |
| 2007 | 0.55x | CN¥64.76 Million | CN¥118.56 Million | CN¥64.76 Million | ▼ -46.2% |
| 2006 | 1.02x | CN¥130.12 Million | CN¥128.19 Million | CN¥130.12 Million | ▲ +101.5% |
| 2005 | 0.50x | CN¥24.51 Million | CN¥48.66 Million | CN¥24.51 Million | ▲ +10.7% |
| 2004 | 0.46x | CN¥25.52 Million | CN¥56.07 Million | CN¥25.52 Million | ▼ -46.0% |
| 2001 | 0.84x | CN¥31.47 Million | CN¥37.30 Million | CN¥31.47 Million | — |